Vermillion & White Wealth Management Group LLC acquired a new stake in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,300 shares of the biotechnology company’s stock, valued at […]
Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Free Report) (TSE:AUP) announced its quarterly earnings data on Thursday. The biotechnology company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.12, Briefing.com reports. The business had revenue of $41.49 million during the quarter, compared to analysts’ expectations of $37.90 million. Aurinia Pharmaceuticals had a […]
Aurinia Pharmaceuticals Inc. (TSE:AUP – Get Free Report) (NASDAQ:AUPH) traded down 3.5% on Monday . The stock traded as low as C$16.41 and last traded at C$16.76. 4,611,683 shares changed hands during trading, an increase of 1,906% from the average session volume of 229,895 shares. The stock had previously closed at C$17.37. Aurinia Pharmaceuticals Stock […]
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) – Equities research analysts at Cantor Fitzgerald issued their FY2024 earnings estimates for shares of Aurinia Pharmaceuticals in a report issued on Tuesday, July 11th. Cantor Fitzgerald analyst O. Brayer forecasts that the biotechnology company will post earnings of ($0.39) per share for the year. The consensus […]
StockNews.com assumed coverage on shares of Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Rating) (TSE:AUP) in a research report report published on Thursday. The firm issued a hold rating on the biotechnology company’s stock. Separately, Royal Bank of Canada lifted their price objective on shares of Aurinia Pharmaceuticals from $11.00 to $13.00 and gave the company an […]